Literature DB >> 17625127

Clinical practice. Management of an inherited predisposition to breast cancer.

Mark Robson1, Kenneth Offit.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17625127     DOI： 10.1056/NEJMcp071286

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  63 in total

1.  Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.

Authors:  Pascal Pujol; Christine Lasset; Pascaline Berthet; Catherine Dugast; Suzette Delaloge; Jean-Pierre Fricker; Isabelle Tennevet; Nathalie Chabbert-Buffet; Pascale This; Karen Baudry; Jerome Lemonnier; Lise Roca; Sylvie Mijonnet; Paul Gesta; Jean Chiesa; Helene Dreyfus; Philippe Vennin; Capucine Delnatte; Yves Jean Bignon; Alain Lortholary; Fabienne Prieur; Laurence Gladieff; Anne Lesur; Krishna B Clough; Catherine Nogues; Anne-Laure Martin
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

Review 2.  Metabolomics as a key integrator for "omic" advancement of personalized medicine and future therapies.

Authors:  Andrea D Eckhart; Kirk Beebe; Mike Milburn
Journal:  Clin Transl Sci       Date:  2012-06       Impact factor: 4.689

Review 3.  Genetic screening: A primer for primary care.

Authors:  Anne Andermann; Ingeborg Blancquaert
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275

4.  Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer.

Authors:  Angela R Bradbury; Linda Patrick-Miller; Lisa Schwartz; Brian Egleston; Colleen Burke Sands; Wendy K Chung; Gord Glendon; Jasmine A McDonald; Cynthia Moore; Paula Rauch; Lisa Tuchman; Irene L Andrulis; Saundra S Buys; Caren J Frost; Theresa H M Keegan; Julia A Knight; Mary Beth Terry; Esther M John; Mary B Daly
Journal:  Pediatrics       Date:  2015-10-19       Impact factor: 7.124

Review 5.  Clinical implications of low-penetrance breast cancer susceptibility alleles.

Authors:  Francis Freisinger; Susan M Domchek
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

6.  Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States.

Authors:  Dezheng Huo; Ruby T Senie; Mary Daly; Saundra S Buys; Shelly Cummings; Jacqueline Ogutha; Kisha Hope; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

Review 7.  Management of breast cancer--part I.

Authors:  Nicholas C Turner; Alison L Jones
Journal:  BMJ       Date:  2008-07-04

8.  Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.

Authors:  Mary S Beattie; Beth Crawford; Feng Lin; Eric Vittinghoff; John Ziegler
Journal:  Genet Test Mol Biomarkers       Date:  2009-02

9.  Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.

Authors:  P Shah; M Rosen; J Stopfer; J Siegfried; R Kaltman; B Mason; K Armstrong; K L Nathanson; M Schnall; S M Domchek
Journal:  Breast Cancer Res Treat       Date:  2009-07-17       Impact factor: 4.872

Review 10.  Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.

Authors:  Ismail Jatoi
Journal:  Eur J Breast Health       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.